Objective To describe the prevalence of obesity as estimated by waist circumference (WC) and body mass index (BMI) and compare associations of WC and BMI with indicators of metabolic, cardiovascular, and renal health in children with chronic kidney disease (CKD).
Conclusions Measurement of WC added limited information to BMI in this cohort. Further longitudinal study is needed to determine how WC and BMI compare in predicting outcomes, particularly for children with CKD identified as having obesity by 1 measure but not the other. (J Pediatr 2017; 191:133-9) .
C hildren with end-stage renal disease have an increased risk of cardiovascular mortality 1 and subclinical manifestations of early cardiovascular disease are found in children with earlier stages of chronic kidney disease (CKD). There are multiple traditional and nontraditional risk factors that contribute to cardiovascular risk in CKD. 2, 3 One traditional risk factor is obesity, a modifiable clinical target. Despite issues with growth and malnutrition in some children with CKD, obesity is commonly observed, with approximately 15% having a body mass index (BMI) >95th percentile 4 and 24% having a BMI >90th percentile. 5 BMI is the most commonly used estimate of obesity in children, but it measures both lean body mass and total fat (ie, general adiposity), and limitations include moderate sensitivity in detecting excess adiposity in children. 6 What is not clear is which estimate of obesity is the most appropriate to use in children with CKD. In CKD, BMI may underestimate the prevalence of obesity given that some patients have reduced muscle mass. BMI also shows a conflicting relationship with adverse outcomes in both the general population and a CKD population 7 ; therefore, BMI may not be the most appropriate measure. Waist circumference (WC) is an estimate of central obesity, which reflects visceral fat, the most relevant type in terms of cardiovascular risk and insulin resistance. As such, it may be a more appropriate indicator of obesity. Despite the appeal of WC, it is frequently not found to provide additional benefit to the use of BMI percentile in the general pediatric population. 8 However, because WC is height independent, it may be a more suitable instrument in the pediatric CKD population, which has substantial height deficits and growth abnormalities.
There are no data on the utility of WC or other central obesity estimates in a pediatric CKD population. The purposes of this study were to (1) describe the prevalence of central obesity in children with CKD by WC and BMI percentile and (2) compare and contrast the relationships between markers of metabolic, cardiovascular, and renal health with WC and BMI z-scores.
Methods
The Chronic Kidney Disease in Children (CKiD) cohort study is a longitudinal, observational study designed to investigate the natural and treated history of pediatric CKD. This multicenter study spans 54 sites in the US and Canada and has enrolled 891 children between the ages of 1 and 16 years from 2005 to 2014. Eligibility for enrollment included an estimated glomerular filtration rate (eGFR) of 30-90 mL/min/ 1.73 m 2 and a diagnosis of CKD. CKD diagnoses were broadly grouped into 2 categories of underlying pathology: glomerular and nonglomerular forms of CKD. These families of CKD diagnoses were described previously 9 and have been shown to have distinct patterns of comorbidities and disease trajectories. Annual study visits collected anthropometric, clinical, and renal health data. Full details of the study have been reported previously. 10 The study was approved by each participating center's institutional review board and written informed consent was obtained from the parents or guardians of subjects. Written assent was obtained from the subjects when applicable.
The primary exposures were WC and BMI. WC measurement was added to the CKiD protocol in June 2008 (approximately 3 years after study inception), and was summarized as the average of 2 or 3 measurements using a Gulick tape measure (Jansen Medical Supply, Houston, TX). Specifically, WC was measured on a standing participant from the horizontal plane 1 cm above the navel with the child instructed to gently breathe out at the time of measurements without holding their abdomen or breath. WC was measured at least twice, with a third measurement taken if the first 2 differed by more than 0.1 cm. WC z-scores and percentiles were calculated by previously published methods based on normal children, specifically, methods that determine continuous (i.e., smoothed) functions of percentiles based on least mean squares tables.
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Because these tables were based on children between 5 and 19 years of age, we restricted our analytic sample to participants within that age range. BMI was calculated from the average of 3 height and weight measurements and converted to ageand sex-specific z-scores according to least mean squares tables. 12 Obesity defined by WC percentiles was determined as being higher than the 94th percentile for boys and 84th percentile for girls, which were found to correspond with Adult Treatment Panel metabolic syndrome criteria for abnormal WC in adult men (102 cm) and women (88 cm) within a large group of children and adolescents with a similar age range to the CKiD population. 13 Obesity determined by age-and sex-specific BMI percentiles was based on a threshold of the 95th percentile for both boys and girls.
14 All analyses were stratified by underlying CKD diagnoses (glomerular vs nonglomerular) because these diagnoses were expected to have different relationships with metabolic, cardiovascular, and renal biomarkers.
Dependent variables were indicators of metabolic, cardiovascular, and renal health. Metabolic variables included fasting total cholesterol (mg/dL), high-density lipoprotein (HDL) cholesterol (mg/dL), non-HDL cholesterol (mg/dL), triglycerides (mg/dL), fasting glucose (mg/dL), and homeostatic model assessment and insulin resistance (HOMA-IR); these variables were measured every other year with the exception of blood glucose (measured every year) and HOMA-IR (measured once in this population). Cardiovascular variables included systolic and diastolic blood pressure (BP) (mm Hg) and were the average of 3 measurements taken at least 30 seconds apart, measured annually, and converted to z-scores according to the normal population, adjusting for age, sex, and height. 15 179 where ht = height in meters, Cr = serum creatinine in mg/dL, CysC = serum cystatin C in mg/dL, and BUN = blood urea nitrogen in mg/dL.
Statistical Analyses
The agreement between obesity defined by WC and by BMI was assessed using the kappa statistic. Because some variables were collected at different time points (eg, BP at all visits and lipids at every other visit), we present descriptive statistics of the first available visit and the number of observations for each outcome (i.e., data from repeat study visits for each subject were used if available). Separate linear regression models were fit for each outcome with the predictor being WC z-scores and BMI z-scores. Outcomes were log-transformed (with the exception of BP z-scores) and the slope from these regression models were presented as the percent change in outcome for a 1-SD change in WC or BMI (based on the normal population). Generalized estimating equations accounted for the repeated measurements within individuals. To compare whether the associations between the outcome with WC or BMI were different, bootstrap methods were used to determine statistically significant differences in the 2 slopes for each outcome and were based on 500 samples. Specifically, each bootstrapped sample was based on a random selection with replacement at the individual level of the same number of subjects as the original study sample. Each subject contributed his or her observed repeated measurements to preserve the withinperson correlation. The test statistic was calculated as the ratio of the difference in slopes (in the numerator) to the SD of these THE JOURNAL OF PEDIATRICS • www.jpeds.com Volume 191 • December 2017 differences (in the denominator). All analyses were conducted in SAS 9.4 (Cary, NC).
Results
Of 891 children enrolled, 737 children between 5 and 19 years of age contributed at least 1 visit with both WC and BMI. A total of 513 children with a nonglomerular diagnosis (mean age, 11 years; 64% boys) and 224 children with a glomerular diagnosis (mean age, 14 years; 52% boys) were included. Table I describes differences between children with nonglomerular and glomerular diagnoses. The duration of CKD at the time of study entry was significantly longer for children with nonglomerular CKD (mean time, 11 years) compared with those with glomerular CKD (mean time, 6 years), which reflects the presence of primarily congenital diseases among children with nonglomerular CKD. Children with nonglomerular diagnoses had substantial height deficits (mean height z-score, −0.58 SD) and normal weight (mean weight z-score, −0.06 SD). Given the shorter stature and normal weight, the BMI (mean BMI z-score, 0.33 SD) was greater than the general pediatric population. Similarly, the average WC (mean WC z-score, 0.23 SD) was also greater than the expected population average (i.e., mean z-score = 0). In contrast, children with glomerular diagnoses did not have as severe height deficits (mean height z-score, −0.19 SD), were substantially heavier (mean weight z-score, 0.59 SD), and correspondingly had higher BMI (BMI z-score, 0.76 SD). The average WC in children with glomerular diagnoses was also higher (mean WC z-score, 0.59 SD). Table II presents agreement by obesity defined by WC percentiles (rows) and BMI percentiles (columns) at baseline and for all person-visits with corresponding kappa statistics. At baseline, there was agreement in the classification of children with or without obesity by WC and BMI in 92% in the nonglomerular CKD group and 87% in the glomerular CKD group. Among children with nonglomerular CKD, 23 (4.5%) had obesity by WC criteria but not BMI criteria, and 19 (3.7%) had obesity by BMI criteria but not WC criteria. The kappa statistic comparing the agreement of these 2 definitions of obesity was 0.68 (95% CI, 0.59-0.77), indicating fair agreement. 17 Among children with glomerular CKD, 21 (9.4%) had obesity by WC criteria but not BMI criteria, and 8 (3.6%) had obesity by BMI criteria but not WC criteria. The corresponding kappa statistic was 0.68 (95% CI, 0.57-0.78). The results were consistent when all person-visits were pooled: the proportion of misclassified children was similar and the kappa statistics were 0.67 and 0.72 for children with nonglomerular and glomerular CKD, respectively. Table III presents descriptive statistics of metabolic, cardiovascular and renal outcome variables at baseline and the total number of person-visits contributing data, stratified by CKD diagnosis. By protocol, total cholesterol, HDL, non-HDL, and triglyceride data were measured at every other annual visit and glucose was measured at each visit. The mean HDL, triglyceride, and glucose levels were similar for children with Values are n (%) unless otherwise noted. For BMI, obesity was defined as ≥95th percentile for all children. For WC, obesity was defined as ≥94th percentile for boys and ≥84th percentile for girls.
13 nonglomerular and glomerular diagnoses. Children with glomerular CKD had higher levels of total cholesterol and non-HDL than children with non-glomerular CKD. HOMA-IR was measured once (n = 221 and 50 for the nonglomerular and glomerular groups, respectively) and was greater in the glomerular group than in the nonglomerular group. For cardiovascular outcomes, systolic and diastolic BP z-scores were determined at every study visit. At baseline, children with nonglomerular CKD had slightly elevated mean systolic BP z-scores (0.23 SD), whereas those with glomerular CKD were closer to normal (0.12 SD). Diastolic BP z-scores were increased at baseline for both groups (0.37 for children with nonglomerular CKD and 0.29 for children with glomerular CKD). LVMI was measured at every other visit and mean levels at baseline were approximately 30 g/m 2.7 for both groups. The urine protein:creatinine ratio and eGFR were measured at each visit. Mean baseline levels of urine protein:creatinine were higher among those with a glomerular diagnosis (1.5 mg/mg creatinine vs 0.8 mg/mg creatinine). These data were right skewed as the median levels were 0.6 and 0.3 mg/mg creatinine, respectively. Mean baseline levels of eGFR were also higher among those with glomerular CKD (63. To determine strength of relationships between WC and BMI z-scores and metabolic, cardiovascular, and renal outcomes, separate linear regressions were performed within each CKD diagnosis group, with WC z-score as the sole independent variable and then BMI z-score as the sole independent variable. The slopes of these were converted to percentages when the outcome was not a z-score and are interpreted as the percent differences associated with a 1-SD increase in WC or BMI. Table IV describes these slopes, as well as the bootstrapped P values comparing whether the slope determined by WC z-score was different than that determined by BMI z-score.
Among children with nonglomerular CKD, WC z-score was significantly associated with HDL cholesterol, non-HDL cholesterol, triglycerides, glucose, HOMA-IR, systolic BP z-score, LVMI, and urine protein:creatinine. In the same group of children, BMI was significantly associated with all these markers except for urine protein:creatinine, but was additionally significantly associated with total cholesterol and diastolic BP z-score. BMI z-score was more strongly associated with LVMI than WC z-score (P = .011). Additionally, for each SD increase, BMI was associated with a 1.68% higher eGFR, although WC was associated with 1.38% lower eGFR, and this difference was statistically significant (P < .001). There were no differences in the relationships comparing WC z-score and BMI z-score for metabolic health outcomes, although BMI z-score was borderline significantly different than WC z-score for total cholesterol (P = .081).
Among children with glomerular CKD, WC z-scores were significantly associated with HDL cholesterol, triglycerides, HOMA-IR, systolic BP z-score, LVMI, and eGFR. BMI z-scores were significantly associated with all these markers except for triglycerides. For each SD increase, BMI was associated with a 6.81% higher eGFR, although WC was associated with a 4.34% higher eGFR. The difference in the strength of association with eGFR between BMI and WC was statistically significant (P = .039). There were no differences in relationships by WC z-scores or BMI z-scores for the remaining 11 outcomes.
Discussion
This study compared WC and BMI in estimating obesity in children with CKD and compared associations between WC and BMI with markers of metabolic, cardiovascular, and renal health. There was good agreement between WC and BMI in categorizing CKiD participants with obesity, indicating that both estimated the same underlying construct. For the most part, WC and BMI had similar direction and strength of univariate associations with markers of metabolic, cardiovascular, and renal health, but BMI was more positively associated with eGFR.
In otherwise healthy children, measures of central adiposity including WC have been shown to predict independently both metabolic risk factors such as dyslipidemia and insulin resistance 18, 19 and cardiovascular risk factors including hypertension, 20 higher carotid intima media thickness, 21 and greater left ventricular mass and diastolic dysfunction. 22 However, other studies have reported no added benefit of central obesity measures to that provided by BMI in children 8, [23] [24] [25] and our results in children with CKD are consistent with these findings.
In our study, children with glomerular causes of CKD had a higher WC and BMI z-score than children with nonglomerular causes of CKD. One potential explanation for this finding is that the nonglomerular CKD group had a longer period of time with CKD before entering the study (11 years vs 6 years), which may have had a greater impact on nutrition and growth (as evidenced by the lower mean average height z-score in the Values are mean ± SD and total person-visits, n. The eGFR is based on the 2012 equation.
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Volume 191 nonglomerular CKD group). Differences in WC and BMI by CKD diagnosis group may also be due to a higher prevalence of corticosteroid use among children with glomerular CKD (26% vs <1%). Although edema was more common among children with glomerular CKD (6.7% vs 1.0%), this low prevalence could not account for the higher WC and BMI z-scores. Obesity estimated by WC and BMI was largely congruent among those children with CKD with kappa values between 0.67 and 0.72. However, approximately 10% of the study population was identified as obese by 1 measure but not the other. The discordance was greatest in children with glomerular CKD who had obesity by WC but did not have obesity by BMI criteria (9.4%). This again may be explained by children with glomerular disease having a greater exposure to corticosteroids, which results in redistribution of body fat to the abdomen. The discordance was less pronounced when the analysis included repeated measurements (6.6%), which may reflect discontinuation of steroid therapy, allowing the body fat to redistribute again out of the abdomen. We used the suggested WC percentile cutoffs by Cook et al 13 because these values were shown in a large population of children to correspond with adult definitions of obesity by WC and given the lack of a universally accepted definition of obesity using WC criteria in children. However, obesity thresholds were different between boys (94th percentile) and girls (84th percentile). This was a potential limitation to compare a single BMI-based threshold for obesity because BMI and WC z-score purport to measure the same construct. However, Kuhle et al 26 found similar thresholds for defining obesity by WC in Canadian children. As a sensitivity analysis, we replicated the agreement analysis in Table II using the 95th percentile of WC as the threshold for both boys and girls and did not find substantially altered kappa statistics (range, 0.67-0.75). Further investigation for validating single or sex-specific obesity thresholds for WC in a normal population is needed.
For most of the univariate associations with metabolic variables, there were no differences between WC and BMI z-scores. Similar to the metabolic indicators, there was generally good agreement between WC z-scores and BMI z-scores and associations with cardiovascular markers. Among children with associations of WC z-scores and BMI z-scores with markers of metabolic, cardiovascular, and The slope from the WC model was compared with the BMI model using bootstrapping methods. Bold indicates P < .05. The eGFR is based on the 2012 equation. 16 nonglomerular CKD, BMI z-scores had a stronger association with LVMI than WC z-scores, and this difference was significant (P = .011). It is unclear if this stronger association was due to the height being a factor in the calculation of both BMI and LVMI or if there was an underlying biological mechanism to account for BMI z-scores being more strongly associated with LVMI relative to WC z-scores. The BP measurements were used regardless of whether or not subjects were taking antihypertensive medications, but because the primary aim was to compare the association of WC and BMI with BP rather than with hypertension category and given the same BP data were used in the univariate associations with WC and BMI, the results comparing how WC and BMI associated with BP were still valid. For the urine protein:creatinine, there was a trend toward a stronger association with WC z-scores compared with BMI z-scores for both glomerular and nonglomerular CKD groups, although these results did not attain statistical significance. This trend was consistent with previous reports associating central adiposity with unfavorable renal hemodynamics and glomerular hyperfiltration after adjustment for BMI 27 and an increased risk for albuminuria has been reported in young adult populations with increased WC. 28 Notably, among children with glomerular CKD, higher WC and BMI z-scores were associated with higher eGFR, with BMI z-scores being more strongly associated than WC z-scores (P = .039). Similarly, longitudinal studies of adult patients with CKD found more favorable outcomes of CKD progression in the overweight and mildly obese BMI ranges, although outcomes worsened with progressively higher BMI. 29 The finding of higher WC and BMI being associated with higher eGFR may reflect wasting and poor appetite associated with more severe CKD 30, 31 or potential nonlinear relationships not captured by the model (as was noted in the study by Lu et al 29 ). Additionally, a higher (and healthier) lean body mass among those with a glomerular diagnosis and obesity may partially explain why higher z-scores of BMI and WC were associated with an increased eGFR.
Among those with nonglomerular CKD, the direction of association of WC z-scores and eGFR was different than that of BMI z-score and eGFR (P < .001), although neither association was significantly different than 0. The reason for the incongruent relationship between WC and BMI and eGFR in the nonglomerular CKD group compared with both WC and BMI having the same direction of relationship with eGFR in the glomerular CKD group is not clear. One possible explanation is that, given the longer duration of CKD before study entry in the nonglomerular CKD group, it is possible that chronic hyperfiltration associated with central obesity resulted in a lower eGFR over time, but we cannot draw conclusions on this hypothesis given the cross-sectional nature of this study. Identifying glomerular hyperfiltration in those with CKD is largely theoretical, and this hypothesis should be explored in other studies. In addition, there may be confounding by steroid use both causing increased WC/BMI and leading to higher eGFR by treating the underlying disease in children with glomerular CKD.
The strengths of this study included the use of a large, wellcharacterized cohort of children with CKD of diverse underlying causes and heterogeneity of body sizes. Additionally, the CKiD protocols ensured standardized procedures, including calculations of BMI and WC, across study sites. There were also several limitations to this study. First, the analyses of univariate associations (Table IV) were based on slope-intercept models and did not account for nonlinearity. These comparisons remained valid because both WC and BMI had the same model constraints. However, these summaries of associations are simplified relationships that were used as metrics of agreement, rather than a comprehensive epidemiologic description of the relationships of WC and BMI with metabolic, cardiovascular, and renal health parameters. Second, HOMA-IR was measured in a small subset of participants and we cautiously present inferences for this outcome owing to the relatively small sample size. Nonetheless, this metabolic outcome was closely related to both WC and BMI z-scores. Third, although the process of measuring WC was standardized across sites, there may be more potential for measurement error in WC than BMI because measurement of WC may be more prone to variation in technique compared with measurement of BMI, which is done with calibrated instruments.
Because WC and BMI provide similar value in classification of obesity and associations with relevant biomarkers, BMI may be preferred to WC in clinical practice because it is may be easier to obtain and interpret. However, further study of these measures appears to be warranted, especially longitudinal assessment of how WC and BMI predict metabolic, cardiovascular, and renal outcomes, particularly for children identified as obese by 1 measure but not the other. 
